Showing results (101-110 of 796) with videos related to
Sort By:
Pageof 80
Nature Cardiovascular Research|March 12, 2025
The journey of the cardiovascular polypill from its conception to the WHO List of Essential MedicinesValentin Fuster, Gines Sanz, Jose M CastellanoNature Reviews. Rheumatology|November 16, 2011
Cardiovascular safety of biologic therapies for the treatment of RAJeffrey D Greenberg, Victoria Furer, Michael E FarkouhCurrent Cardiology Reports|June 8, 2012
Periprocedural myocardial enzyme elevation: prognostic implications for current practiceSanjum S Sethi, Avtar Singh, Michael E FarkouhThe American Journal of Medicine|December 31, 2002
The vulnerable plaque and acute coronary syndromesRoberto Corti, Michael E Farkouh, Juan Jose BadimonCurrent Opinion in Cardiology|July 12, 2018
Diabetes and multivessel disease: coronary artery bypass grafting remains kingLucas Colombo Godoy, Vivek Rao, Michael E FarkouhJournal of the American College of Cardiology|March 19, 2013
Risk factor control for coronary artery disease secondary prevention in large randomized trialsMichael E Farkouh, William E Boden, Vera Bittner, et al.Lancet (London, England)|September 13, 2011
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trialZahi A Fayad, Venkatesh Mani, Mark Woodward, et al.Journal of the American College of Cardiology|September 3, 2016
Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary DiseaseG B John Mancini, Michael E Farkouh, Maria M Brooks, et al.Nature Reviews. Cardiology|March 31, 2010
Marfan syndrome. Part 1: pathophysiology and diagnosisVictoria Cañadas, Isidre Vilacosta, Isidoro Bruna, et al.Vascular Medicine (London, England)|July 3, 2004
A teenager with mixed connective tissue disease presenting with an acute coronary syndromeJames J Jang, Jeffrey W Olin, Valentin FusterPageof 80